Results 141 to 150 of about 379,288 (191)

Case presentation: a severe case of cobalamin c deficiency presenting with nephrotic syndrome, malignant hypertension and hemolytic anemia. [PDF]

BMC Nephrol
Akar HT, Yıldız H, Öztürk Z, Karakaya D, Sezer A, Olgaç A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

PROTEINURIA IN MALIGNANT HYPERTENSION

Lancet, The, 1968
Abstract Proteinuria was investigated in 28 patients with malignant hypertension. All had proteinuria at some time during the course of their disease. There was a wide variation in the degree of proteinuria. Severe, persistent hypertension with progressive deterioration in renal function is commonly associated with massive proteinuria.
Robertm Kark, Robert M Kark
exaly   +3 more sources

The Renin-Angiotensin System in Malignant Hypertension Revisited: Plasma Renin Activity, Microangiopathic Hemolysis, and Renal Failure in Malignant Hypertension

American Journal of Hypertension, 2007
BACKGROUND: Malignant hypertension is a renin-dependent form of hypertension. However, the variations in renin-angiotensin system (RAS) activation in malignant hypertension are not completely understood. A proposed mechanism for ongoing RAS activation is
Richard P Koopmans, Gert A Van Montfrans, Van Montfrans Gert A   +2 more
exaly   +2 more sources

Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension

Hypertension, 2011
Endothelial dysfunction is characteristic of patients with essential hypertension, but only limited data are available on different aspects of endothelial function in patients with malignant-phase hypertension.
Alena Shantsila, , Eduard Shantsila
exaly   +2 more sources

Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

Kidney International, 2019
Malignant hypertension is listed among the causes of secondary thrombotic microangiopathy, but pathogenic mutations in complement genes have been reported in patients with hypertension-induced thrombotic microangiopathy.
TERESA Cavero, Karina Soto, Fernando Caravaca-Fontan   +2 more
exaly   +2 more sources

Malignant hypertension and hypertensive encephalopathy

The American Journal of Medicine, 1953
Abstract Twenty-seven patients with severe hypertension, most of whom exhibited various degrees fof encephalopathy, were treated with continuous infusions of intravenous veriloid. The blood pressure decreased significantly in all patients. Seventeen patients were maintained on continuous infusions for prolonged periods of time with improvement of the ...
J H, MOYER, S I, MILLER, A B, TASHNER, H, SNYDER, R O, BOWMAN   +4 more
openaire   +2 more sources

Microangiopathic Hemolysis and Renal Failure in Malignant Hypertension

Hypertension, 2005
Renal dysfunction is an important cause of morbidity and mortality in patients with malignant hypertension. Microangiopathic hemolysis (MAHA) related to malignant hypertension may cause renal insufficiency by obstruction of interlobular arteries.
Richard P Koopmans, Gert A Van Montfrans
exaly   +2 more sources

THE REVERSIBILITY OF MALIGNANT HYPERTENSION

The Lancet, 1952
AbstractIn 1952 three patients were described, who had extremely high arterial pressure, fully developed neuroretinopathy, and arteriolar necrosis in kidneys and adrenals. In all, arterial pressure was reduced by surgery, retinopathy resolved, and the patients survived for six years. In all these the primary lesion was pyelonephritis.
G W, PICKERING, A D, WRIGHT, R H, HEPTINSTALL   +2 more
openaire   +2 more sources

THE MANAGEMENT OF MALIGNANT HYPERTENSION

Annals of Internal Medicine, 1953
Excerpt INTRODUCTION Hypertension varies strikingly in its clinical course. One of the unexplained vagaries of this condition is the fact that in some instances the disease may be most benign, with...
M, SOKOLOW, M F, SCHOTTSTAEDT
openaire   +2 more sources